// App-Quantinova.ai

755 : Immune Responses and Disease Marker Changes Following SARS-CoV-2 mRNA Vaccination in a Cohort of Rheumatic Disease Patients

Researchers

Presenter

  • Hu Zeng

Principal Investigators

  • Zesheng An

  • Xian Zhou

  • Yanfeng Li

  • Jane Jaquith

  • Kathleen McCarthy-Fruin

  • Kenneth J. Warrington

  • Ali Duarte-Garcia

  • Uma Thanarajasingam

  • Cornelia M. Weyand

Medical Centers

  • Mayo Clinic, Rochester, MN

  • Mayo Clinic School of Medicine, Rochester, MN, and Stanford University, Stanford, CA

Locations

  • United Kingdom

  • United States

Companies

  • N/A

Study Components

Therapeutic Area

  • Infectious Diseases (ID)

  • Autoimmune (AI)

  • Dermatology

  • Musculoskeletal

Disease

  • Lupus

  • Ankylosing spondylitis

  • Psoriatic arthritis

  • Sjogren's syndrome

  • Inflammatory Arthritis

  • Myositis

  • Coronavirus disease

Biomarkers

  • Peripheral blood mononuclear cell

  • Immunoglobulin A

  • Interferon Induced Protein 44

  • Immunoglobulin G

Drug/Treatment

  • Interferon

Outcome

  • N/A

Study Design

  • Cohort

Phase

  • N/A

Study Id's

  • N/A

Sponsors

  • N/A

Result

  • N/A

Copyright © 2026. QuantiNova All rights reserved